Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$428,657,506
-$278,104,649 QoQ
Shares Held
5,031,782
-53.1% QoQ
Ownership
3.62%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. CYTK ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in CYTK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $447,126,445 | 5,248,579 | Shares | Sole | 2026-07-08 | |
| 2026-06-30 | $428,657,506 | 5,031,782 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $706,762,155 | 10,723,140 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $813,804,559 | 12,807,752 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $719,516,917 | 13,091,647 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $372,278,561 | 11,267,511 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $414,605,304 | 10,316,131 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $507,782,028 | 10,794,686 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $638,576,609 | 12,094,254 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $624,323,072 | 11,523,128 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $764,279,134 | 10,901,143 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,086,019,802 | 13,007,783 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $353,249,673 | 11,990,824 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $396,756,014 | 12,162,968 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $452,712,731 | 12,864,812 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $612,153,274 | 13,359,958 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $624,456,109 | 12,888,671 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $503,063,696 | 12,803,861 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $467,721,331 | 12,706,366 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $571,598,221 | 12,540,549 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $446,214,148 | 12,485,007 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $167,991,016 | 8,488,682 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $89,358,011 | 3,841,703 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $21,560,725 | 1,037,571 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $72,649,194 | 3,355,621 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $82,703,522 | 3,508,847 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $34,574,150 | 2,932,498 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||